PTC Therapeutics, Inc.

RTW Investments aims to generate attractive risk-adjusted returns through investments in securities, both equity and debt, long and short, of companies with a focus on the healthcare sector. The Funds will primarily invest in the equity and debt of public and private issuers globally, with a focus on the US and Europe. Derivatives are employed to improve payoff structures, as well as to construct hedges. The firm’s research process will be focused on a scientific approach to assessing and accurately defining the fundamental value of outcomes surrounding transformational events in the lifecycle of healthcare companies.

TimesSquare is a fundamental research-oriented, growth equity investment management firm that specializes in Small-Cap, Small/Mid-Cap, Mid-Cap, and concentrated growth equity strategies. The firm seeks build diversified portfolios of growth stocks that generate excellent risk-adjusted returns. Proprietary fundamental research drives their disciplined, bottom-up process of selecting companies that meet their definition of a superior growth business. Each of their investment strategies is managed by a portfolio manager or group of portfolio managers in a manner consistent with their approach to investing. In general, TimesSquare looks for a targeted range of price appreciation potential generally over a 12 to 18 month investment horizon. The firm may also consider the probability of retaining/widening margins, proportion of recurring revenues, strength of balance sheet, barriers to entry and competitive landscape, management track record, and market visibility.

Armistice Capital is a global, long/short, value-oriented and event-driven hedge fund firm which focuses primarily on the health care and consumer sectors. They invest predominantly in equities and can be opportunistic across the capital structure. The firm seeks to maximize the opportunity set of investment candidates allowing for the selection of unique, concentrated bets to generate uncorrelated returns. They maintain significant position and portfolio level hedges in an effort to mitigate basis and market risks. Armistice Capital employs a bottom-up analysis, assessing all components of the company’s capital structure and aims to take larger positions where the greatest potential risk adjusted return exists. Armistice Capital’s Domestic Fund and the Offshore Fund, through their investments in the Master Fund, seek to achieve long-term capital appreciation by employing an opportunistic global long/short strategy for investing in distressed debt, value equities and event equities. In all of its investing activities, the Funds will seek to emphasize capital preservation and will seek to mitigate risk through various hedging strategies at both the position and portfolio levels.

ACM manages the Adage Capital Partners Fund (ACP). The firm seeks to achieve its objective through stock selection based primarily on intra-industry fundamental analysis with a dedicated focus on intra-industry valuation methodologies. Primary research is a central component of their investment process. ACM utilizes a staff of portfolio managers and equity analysts dedicated to tracking specific sectors represented within the Index that utilize a stock valuation methodology designed for each specific sector in selecting the investments of ACP. The firm currently utilizes one non-industry specific analyst, focusing on risk arbitrage opportunities for ACP. They may employ additional analysts and/or portfolio managers in the future, focusing on non-industry specific methodologies for identifying investments for ACP, and in connection with such methodologies ACM may cause ACP engage in additional types of investments, such as leveraged trading and/or risk arbitrage or other event driven trading.

Bay City Capital invests in both private and public life sciences companies located in the US. The firm targets companies operating in the fields of biopharmaceuticals, drug discovery, medical devices and diagnostics. They acts as lead/co-lead investor and provides financing for seed, early and later stage capital requirements. They takes a seat on the board of directors and makes co-investments.

Vulcan ventures Inc seeks investment opportunities in companies located in the US. The firm focuses on companies with an experienced management team, recurring revenues and substantial free cash flows. It targets companies operating in the fields of media conglomerates, energy minerals, financial services, healthcare services, life science and communication. It provides financing for early stage capital requirements.